This chart shows the pharmaceutical companies with the most patents in Australia. Patents must be filed in each country (or, […]
Source
Which pharmaceutical companies have the most drug patents in Australia? Read Post »
Patent Expirations and Generic Competition This week saw several major blockbuster drugs facing patent expirations, potentially opening the market for […]
Source
Here’s a biotech week in review for this week: The biotech sector saw several notable developments this week, with clinical
Annual Drug Patent Expirations for XYWAV Xywav is a drug marketed by Jazz and is included in one NDA. It […]
Source
Annual Drug Patent Expirations for XYREM Xyrem is a drug marketed by Jazz Pharms and is included in one NDA. […]
Source
Annual Drug Patent Expirations for MOVANTIK Movantik is a drug marketed by Valinor and is included in one NDA. It […]
Source
Annual Drug Patent Expirations for RINVOQ Rinvoq is a drug marketed by Abbvie and is included in two NDAs. It […]
Source
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd […]
Source
New tentative approval for Alembic drug dabigatran etexilate mesylate Read Post »
The fields of biotechnology and advanced drug delivery systems are rapidly converging, ushering in a new era of precision medicine
The landscape of cancer treatment is undergoing a dramatic transformation, driven by groundbreaking advances in biotechnology. From gene editing to
Biotechnology and Cancer: A Revolutionary Approach to Treatment Read Post »
Get new actionable insights and updates from BiotechBlog
